Login

UNDEFINED: wu-login-soft-user-unknown

 
CzMA JEP: Current issue
About the journal
Archive
Editorial Board
Redaction
Subscription
For authors and reviewers
Contact us

Transfusion and Haematology Today

Cytomorphology of mature CD5-positive B-cell neoplasms

Cytomorphology of mature CD5-positive B-cell neoplasms

Diagnosis of mature CD5-positive B-cell neoplasms is multidisciplinary. The goal of this study was to evaluate the diagnostic significance of cytomorphology in 233 diagnostic...

Full article   Transfusion and Haematology Today Issue: 3/2017

Specialization: Clinical oncology Internal medicine Haematology
Long-term treatment results of chronic myelomonocytic leukaemia in selected haematological centres

Long-term treatment results of chronic myelomonocytic leukaemia in selected haematological centres

Backgrounds: Chronic myelomonocytic leukaemia (CMML) is a relatively rare neoplastic disorder with features of both myelodysplastic and myeloproliferative diseases. The aim of...

Full article   Transfusion and Haematology Today Issue: 3/2017

Specialization: Clinical oncology Internal medicine Haematology
Blastic plasmacytoid dendritic cell neoplasm: case report and literature review

Blastic plasmacytoid dendritic cell neoplasm: case report and literature review

Blastic plasmacytoid dendritic cell neoplasm represents a rare hematologic malignancy of aggressive biology and unfavourable prognosis. This disease is characterised by primary...

Full article   Transfusion and Haematology Today Issue: 3/2017

Specialization: Haematology Internal medicine Clinical oncology
Acquired angioedema with C1 inhibitor deficiency in a patient with low-grade B-lymphoma and the effect of underlying disease treatment on angioedema manifestations

Acquired angioedema with C1 inhibitor deficiency in a patient with low-grade B-lymphoma and the effect of underlying disease treatment on angioedema manifestations

Acquired angioedema with C1 inhibitor deficiency is a rare disease manifesting as recurrent angioedema of the skin and mucous membranes in different locations. It is usually...

Full article   Transfusion and Haematology Today Issue: 3/2017

Specialization: Haematology Internal medicine Clinical oncology
Idarucizumab: a single centre experience

Idarucizumab: a single centre experience

New direct oral anticoagulants (DOACs) are widely used in the primary and secondary prevention of embolic stroke in patients with atrial fibrillation and risk factors according...

Full article   Transfusion and Haematology Today Issue: 3/2017

Specialization: Clinical oncology Internal medicine Haematology
Management of major surgery in patients with haemophilia A using continuous infusion vs. bolus injections of FVIII – a pharmacokinetic approach to treatment

Management of major surgery in patients with haemophilia A using continuous infusion vs. bolus injections of FVIII – a pharmacokinetic approach to treatment

Management of major surgery represents the most challenging issue of replacement therapy in severe haemophilia. The aim of our open, prospective, nonrandomised study was to...

Full article   Transfusion and Haematology Today Issue: 2/2017

Specialization: Haematology Internal medicine Clinical oncology
Interferon alpha in the treatment of Philadelphia-negative myeloproliferative neoplasms

Interferon alpha in the treatment of Philadelphia-negative myeloproliferative neoplasms

Introduction: Interferon alfa (IFN-α) has been used for over 30 years to treat myeloproliferative neoplasms. Recombinant IFN-α (rIFN-α) and pegylated IFN-α (Peg-IFN-α) have...

Full article   Transfusion and Haematology Today Issue: 2/2017

Specialization: Haematology Internal medicine Clinical oncology
Modern therapy of acute myeloid leukaemia

Modern therapy of acute myeloid leukaemia

Acute myeloid leukaemia is a clonal malignant disease affecting mainly elderly patients. This previously nearly always fatal disease is now curable in 35–40 % of younger...

Full article   Transfusion and Haematology Today Issue: 1/2017

Specialization: Clinical oncology Internal medicine Haematology
Experience with ruxolitinib in the treatment of myelofibrosis and polycythaemia vera at Czech haematological institutions

Experience with ruxolitinib in the treatment of myelofibrosis and polycythaemia vera at Czech haematological institutions

Backgrounds: Ruxolitinib, a Janus kinase 1 and 2 inhibitor, demonstrated efficacy in patients with myelofibrosis and polycythaemia vera in the randomized COMFORT-I, COMFORT-II...

Full article   Transfusion and Haematology Today Issue: 1/2017

Specialization: Haematology Internal medicine Clinical oncology
Autoimmune haemolytic anaemia – diagnosis and treatment, including erythrocyte transfusions

Autoimmune haemolytic anaemia – diagnosis and treatment, including erythrocyte transfusions

Diagnosis of autoimmune haemolytic anaemia (AIHA) is usually quite straightforward. It is based on the clinical and laboratory presentation of haemolytic anaemia and serological...

Full article   Transfusion and Haematology Today Issue: 1/2017

Specialization: Haematology Internal medicine Clinical oncology
 

Most read